Obesity Exacerbates Coxsackievirus Infection via Lipid-Induced Mitochondrial Reactive Oxygen Species Generation

키워드

참고문헌 (67)

1. Stefan N, "Obesity and impaired metabolic health in patients with COVID-19", Nat Rev Endocrinol, 16, pp.341~342 (2020)
2. Karjala Z, "Association between HSV1 seropositivity and obesity : data from the National Health and Nutritional Examination Survey, 2007–2008", PLoS One, 6, pp.e19092~ (2011)
3. Honce R, "Impact of obesity on influenza a virus pathogenesis, immune response, and evolution", Front Immunol, 10, pp.1071~ (2019)
4. Fairweather D, "Update on coxsackievirus B3 myocarditis", Curr Opin Rheumatol, 24, pp.401~407 (2012)
5. Huber S, "Coxsackievirus-induced pancreatitis", Viral Immunol, 17, pp.358~369 (2004)
6. Pedersen KW, "Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex", J Virol, 73, pp.2016~2026 (1999)
7. Limpens RW, "The transformation of enterovirus replication structures : a three-dimensional study of single-and doublemembrane compartments", MBio, 2, pp.e00166~11 (2011)
8. Knoops K, "SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum", PLoS Biol, 6, pp.e226~ (2008)
9. Liu Z, "Role of ros and nutritional antioxidants in human diseases", Front Physiol, 9, pp.477~ (2018)
10. Guillin OM, "Selenium, selenoproteins and viral infection", Nutrients, 11, pp.2101~ (2019)
11. Chi J, "Nox4-dependent ROS production is involved in CVB3-induced myocardial apoptosis", Biochem Biophys Res Commun, 503, pp.1641~1644 (2018)
12. Wang Y, "Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis", Am J Physiol Heart Circ Physiol, 307, pp.H1438~H1447 (2014)
13. To EE, "Mitochondrial reactive oxygen species contribute to pathological inflammation during influenza a virus infection in mice", Antioxid Redox Signal, 32, pp.929~942 (2020)
14. Li J, "Parkin impairs antiviral immunity by suppressing the mitochondrial reactive oxygen species-nlrp3 axis and antiviral inflammation", iScience, 16, pp.468~484 (2019)
15. Sreekanth GP, "Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection", Antiviral Res, 166, pp.42~55 (2019)
16. Hu M, "Subversion of host cell mitochondria by RSV to favor virus production is dependent on inhibition of mitochondrial complex I and ROS generation", Cells, 8, pp.1417~ (2019)
17. 홍은혜, "Morin Hydrate Inhibits Influenza Virus entry into Host Cells and Has Anti-inflammatory Effect in Influenza-infected Mice", Immune Network, 20(4), pp.1~15 (2020), 대한면역학회[DOI]
18. Kim SR, "Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation", Antiviral Res, 151, pp.87~96 (2018)
19. Shi H, "White adipose tissue sensory nerve denervation mimics lipectomy-induced compensatory increases in adiposity", Am J Physiol Regul Integr Comp Physiol, 289, pp.R514~R520 (2005)
20. Henke A, "Apoptosis in coxsackievirus B3-caused diseases : interaction between the capsid protein VP2 and the proapoptotic protein siva", J Virol, 74, pp.4284~4290 (2000)
21. Limsuwat N, "Influence of cellular lipid content on influenza A virus replication", Arch Virol, 165, pp.1151~1161 (2020)
22. Dias SSG, "Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators", PLoS Pathog, 16, pp.e1009127~ (2020)
23. Burckhardt CJ, "Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure", Cell Host Microbe, 10, pp.105~117 (2011)
24. Serrano M, "Coxsackie and adenovirus receptor is increased in adipose tissue of obese subjects : a role for adenovirus infection?", J Clin Endocrinol Metab, 100, pp.1156~1163 (2015)
25. Funke C, "Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells", J Gen Virol, 91, pp.1959~1970 (2010)
26. Soto-Heredero G, "Interorganelle communication between mitochondria and the endolysosomal system", Front Cell Dev Biol, 5, pp.95~ (2017)
27. Sugiura A, "A new pathway for mitochondrial quality control : mitochondrial-derived vesicles", EMBO J, 33, pp.2142~2156 (2014)
28. Picca A, "Generation and release of mitochondrial-derived vesicles in health, aging and disease", J Clin Med, 9, pp.1440~ (2020)
29. Burgyan J, "The 5′-terminal region of a tombusvirus genome determines the origin of multivesicular bodies", J Gen Virol, 77, pp.1967~1974 (1996)
30. Bass VL, "Oleic acid and derivatives affect human endothelial cell mitochondrial function and vasoactive mediator production", Lipids Health Dis, 19, pp.128~ (2020)
31. Bozi LH, "Mitochondrial-derived vesicles : a new player in cardiac mitochondrial quality control", J Physiol, 594, pp.6077~6078 (2016)
32. Neuspiel M, "Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers", Curr Biol, 18, pp.102~108 (2008)
33. Cadete VJ, "Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system", J Physiol, 594, pp.5343~5362 (2016)
34. Li B, "Mitochondrial-derived vesicles protect cardiomyocytes against hypoxic damage", Front Cell Dev Biol, 8, pp.214~ (2020)
35. Gremmels H, "Oleic acid increases mitochondrial reactive oxygen species production and decreases endothelial nitric oxide synthase activity in cultured endothelial cells", Eur J Pharmacol, 751, pp.67~72 (2015)
36. Cheng ML, "Enterovirus 71 induces mitochondrial reactive oxygen species generation that is required for efficient replication", PLoS One, 9, pp.e113234~ (2014)
37. Bond ST, "The antioxidant moiety of mitoq imparts minimal metabolic effects in adipose tissue of high fat fed mice", Front Physiol, 10, pp.543~ (2019)
38. Ghilotti F, "Obesity and risk of infections : results from men and women in the Swedish National March Cohort", Int J Epidemiol, 48, pp.1783~1794 (2019)
39. Falagas ME, "Obesity and infection", Lancet Infect Dis, 6, pp.438~446 (2006)
40. Kwok S, "Obesity : a critical risk factor in the COVID-19 pandemic", Clin Obes, 10, pp.e12403~ (2020)
41. Torres L, "The intriguing relationship between obesity and infection", J Infect(Grand Rapids), 1, pp.6~10 (2018)
42. Namkoong H, "Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice", Biochem Biophys Res Commun, 513, pp.405~411 (2019)
43. Gebhard JR, "Coxsackievirus B3-induced myocarditis : perforin exacerbates disease, but plays no detectable role in virus clearance", Am J Pathol, 153, pp.417~428 (1998)
44. Daley AJ, "A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis", J Paediatr Child Health, 34, pp.196~198 (1998)
45. WolffG, "Double-membrane vesicles as platforms for viral replication", Trends Microbiol, 28, pp.1022~1033 (2020)
46. Cook GW, "Structural variation and its potential impact on genome instability : novel discoveries in the EGFR landscape by long-read sequencing", PLoS One, 15, pp.e0226340~ (2020)
47. Peters CE, "Return of the neurotropic enteroviruses : co-opting cellular pathways for infection", Viruses, 13, pp.166~ (2021)
48. Ormseth MJ, "Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus", Lupus, 22, pp.26~33 (2013)
49. Muro E, "Lipids in cell biology : how can we understand them better?", Mol Biol Cell, 25, pp.1819~1823 (2014)
50. Molteni CG, "Reactive oxygen and nitrogen species during viral infections", Free Radic Res, 48, pp.1163~1169 (2014)
51. Camini FC, "Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress", Antiviral Res, 158, pp.8~12 (2018)
52. Paul D, "Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment", J Virol, 87, pp.10612~10627 (2013)
53. Melia CE, "Escaping host factor pi4kb inhibition : Enterovirus genomic RNA replication in the absence of replication organelles", Cell Reports, 21, pp.587~599 (2017)
54. Soubannier V, "A vesicular transport pathway shuttles cargo from mitochondria to lysosomes", Curr Biol, 22, pp.135~141 (2012)
55. Abuaita BH, "Mitochondria-derived vesicles deliver antimicrobial reactive oxygen species to control phagosome-localized staphylococcus aureus", Cell Host Microbe, 24, pp.625~636 (2018)
56. Uchil P, "Viral entry : a detour through multivesicular bodies", Nat Cell Biol, 7, pp.641~642 (2005)
57. Chu H, "Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways", Curr Top Microbiol Immunol, 339, pp.67~84 (2009)
58. Kelso GF, "Selective targeting of a redox-active ubiquinone to mitochondria within cells : antioxidant and antiapoptotic properties", J Biol Chem, 276, pp.4588~4596 (2001)
59. Kelso GF, "Prevention of mitochondrial oxidative damage using targeted antioxidants", Ann N Y Acad Sci, 959, pp.263~274 (2002)
60. Smith RA, "Delivery of bioactive molecules to mitochondria in vivo", Proc Natl Acad Sci U S A, 100, pp.5407~5412 (2003)
61. Weiss L, "Anti-hepatitis B virus activity of N-acetyl-L-cysteine(NAC) : new aspects of a well-established drug", Antiviral Res, 32, pp.43~53 (1996)
62. Gaudernak E, "Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses", J Virol, 76, pp.6004~6015 (2002)
63. Schweizer M, "Oxidative stress in cells infected with bovine viral diarrhoea virus : a crucial step in the induction of apoptosis", J Gen Virol, 80, pp.1147~1155 (1999)
64. Si X, "Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway", J Virol, 79, pp.8014~8023 (2005)
65. Wang Z, "The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis", PLoS One, 8, pp.e75044~ (2013)
66. Marchant D, "The impact of CVB3 infection on host cell biology", Curr Top Microbiol Immunol, 323, pp.177~198 (2008)
67. Perna AF, "Therapy of hyperhomocysteinemia in hemodialysis patients : effects of folates and N-acetylcysteine", J Ren Nutr, 22, pp.507~514 (2012)

관련 논문AI추천